Pilot study on anti‐reflux mucoplasty: Advancing endoscopic anti‐reflux therapy for gastroesophageal reflux disease
Digestive Endoscopy2023Vol. 36(6), pp. 690–698
Citations Over TimeTop 10% of 2023 papers
Haruhiro Inoue, Kazuki Yamamoto, Yuto Shimamura, Daisuke Azuma, Kei Ushikubo, Hiroki Okada, Yoshiaki Kimoto, Yohei Nishikawa, Ippei Tanaka, Mayo Tanabe, Manabu Onimaru, Marc Julius Navarro
Abstract
This study presents the first pilot report of ARM-P, demonstrating its procedural safety, technical feasibility, and short-term efficacy.
Related Papers
- → Characteristics of symptomatic belching in patients with belching disorder and patients who exhibit gastroesophageal reflux disease with belching(2021)11 cited
- Long-term treatment with proton pump inhibitor is associated with undesired weight gain(2009)
- → Fasting gastric pH can predict the likelihood of pathologic esophageal reflux in gerd patients treated with a proton pump inhibitor(2003)
- Proton pump inhibitor step-down therapy for GERD：A multi-center study in Japan(2011)
- → Prevalence rate of type of gastroesophageal junction in patients with gastroesophageal reflux disease (GERD) and patients without GERD.(2016)